Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,447 | 401 | 95.3% |
| Education | $205.74 | 14 | 3.6% |
| Gift | $60.37 | 76 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,373 | 100 | $0 (2024) |
| AbbVie Inc. | $901.45 | 71 | $0 (2023) |
| ASCEND Therapeutics US, LLC | $621.59 | 177 | $0 (2021) |
| TherapeuticsMD, Inc. | $439.54 | 38 | $0 (2021) |
| Duchesnay USA Incorporated | $279.76 | 11 | $0 (2019) |
| Amgen Inc. | $278.14 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $245.74 | 6 | $0 (2024) |
| Allergan, Inc. | $189.80 | 10 | $0 (2020) |
| Myovant Sciences Inc. | $186.43 | 9 | $0 (2022) |
| AMAG Pharmaceuticals, Inc. | $163.90 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.02 | 6 | Astellas Pharma US Inc ($31.50) |
| 2023 | $280.38 | 6 | Astellas Pharma US Inc ($125.00) |
| 2022 | $518.95 | 38 | PFIZER INC. ($229.72) |
| 2021 | $1,363 | 120 | PFIZER INC. ($356.76) |
| 2020 | $739.23 | 44 | PFIZER INC. ($239.96) |
| 2019 | $968.51 | 95 | AbbVie, Inc. ($141.80) |
| 2018 | $1,017 | 82 | Duchesnay USA Incorporated ($228.56) |
| 2017 | $705.42 | 100 | PFIZER INC. ($221.90) |
All Payment Transactions
491 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: Bone Health | ||||||
| 12/05/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.87 | General |
| 10/23/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: WOMENS HEALTH | ||||||
| 07/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: Biological | ||||||
| 06/23/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $18.78 | General |
| Category: Coronary | ||||||
| 06/05/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 11/06/2023 | Medtronic, Inc. | LIGASURE (Device) | Food and Beverage | In-kind items and services | $75.89 | General |
| Category: Vessel Sealing | ||||||
| 10/19/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Biological | ||||||
| 06/21/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $7.03 | General |
| 06/05/2023 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: WOMENS HEALTH | ||||||
| 01/18/2023 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 01/11/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $45.61 | General |
| Category: Oncology | ||||||
| 12/06/2022 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 11/23/2022 | ABBVIE INC. | ORIAHNN (Drug), LO LOESTRIN FE, ORILISSA | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: WOMENS HEALTH | ||||||
| 11/23/2022 | ABBVIE INC. | ORIAHNN (Drug), LO LOESTRIN FE, ORILISSA | Food and Beverage | In-kind items and services | $0.14 | General |
| Category: WOMENS HEALTH | ||||||
| 11/17/2022 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 11/14/2022 | ABBVIE INC. | ORIAHNN (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: WOMENS HEALTH | ||||||
| 10/27/2022 | ABBVIE INC. | ORIAHNN (Drug), ORILISSA, LO LOESTRIN FE | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: WOMENS HEALTH | ||||||
| 10/27/2022 | ABBVIE INC. | ORIAHNN (Drug), ORILISSA, LO LOESTRIN FE | Food and Beverage | In-kind items and services | $0.16 | General |
| Category: WOMENS HEALTH | ||||||
| 10/04/2022 | ABBVIE INC. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: WOMENS HEALTH | ||||||
| 09/28/2022 | PFIZER INC. | PREMARIN (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: WOMENS HEALTH | ||||||
| 09/19/2022 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 09/14/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: HORMONE THERAPY | ||||||
| 08/31/2022 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 08/10/2022 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,128 | 1,206 | $118,190 | $55,592 |
| 2022 | 13 | 1,499 | 1,701 | $205,075 | $100,554 |
| 2021 | 14 | 1,465 | 1,622 | $188,965 | $89,904 |
| 2020 | 11 | 1,179 | 1,345 | $145,945 | $68,928 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 172 | 184 | $27,600 | $16,290 | 59.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 200 | 236 | $23,775 | $15,127 | 63.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 215 | 215 | $43,000 | $9,217 | 21.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 170 | 170 | $7,650 | $7,497 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 66 | 66 | $4,950 | $2,506 | 50.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $2,975 | $2,007 | 67.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,200 | $1,029 | 46.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 259 | 289 | $2,890 | $985.49 | 34.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 18 | 18 | $3,150 | $932.21 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 306 | 356 | $53,400 | $33,901 | 63.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 240 | 315 | $31,800 | $22,387 | 70.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 279 | 279 | $55,800 | $12,139 | 21.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 217 | 217 | $9,740 | $9,620 | 98.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 41 | $7,175 | $5,386 | 75.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $7,875 | $4,368 | 55.5% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Facility | 2022 | 18 | 18 | $18,000 | $3,538 | 19.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 48 | 51 | $3,825 | $2,246 | 58.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $3,000 | $2,039 | 68.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $5,000 | $1,937 | 38.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 255 | 326 | $3,260 | $1,121 | 34.4% |
| 58100 | Biopsy of lining of uterus | Office | 2022 | 11 | 11 | $3,575 | $1,011 | 28.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 15 | 15 | $2,625 | $858.01 | 32.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 238 | 271 | $40,700 | $27,162 | 66.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 213 | 279 | $28,000 | $19,496 | 69.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 328 | 328 | $65,600 | $14,389 | 21.9% |
About Renee Cotter, MD A PROFESSIONAL CO
Renee Cotter, MD A PROFESSIONAL CO is a Specialist healthcare provider based in West Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861569428.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Renee Cotter, MD A PROFESSIONAL CO has received a total of $5,713 in payments from pharmaceutical and medical device companies, with $121.02 received in 2024. These payments were reported across 491 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,447).
As a Medicare-enrolled provider, Cotter has provided services to 5,271 Medicare beneficiaries, totaling 5,874 services with total Medicare billing of $314,978. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location West Hills, CA
- Active Since 11/29/2006
- Last Updated 11/16/2015
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861569428
Products in Payments
- PREMARIN (Drug) $726.23
- MYFEMBREE (Drug) $464.92
- LO LOESTRIN FE (Drug) $345.80
- SPRIX (Drug) $339.55
- ORILISSA (Drug) $326.48
- Osphena (Drug) $279.76
- ANNOVERA (Drug) $266.70
- ESTROGEL (Drug) $263.48
- PVC (Drug) $259.10
- Orilissa (Drug) $184.26
- INTRAROSA (Drug) $163.90
- Veozah (Drug) $156.50
- Prolia (Biological) $149.53
- EVENITY (Biological) $119.99
- ORIAHNN (Drug) $106.58
- NUVARING (Drug) $101.79
- Tymlos (Biological) $96.08
- MYRBETRIQ (Drug) $89.24
- IMVEXXY (Drug) $89.07
- PROTIVA (Drug) $86.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in West Hills
Dr. Cyrus Badii, M.d, M.D
Specialist — Payments: $8,075
Shervin Aminpour, Md, MD
Specialist — Payments: $6,257
Dr. Douglas Gellerman, Md, MD
Specialist — Payments: $4,285
Niloufar Guiv, M.d, M.D
Specialist — Payments: $3,527
Michael Safir, M.d, M.D
Specialist — Payments: $2,149
Dr. Zareh Vartivarian, M.d, M.D
Specialist — Payments: $1,530